Vinpocetine

DB12131InvestigationalSmall molecule

Vinpocetine is a synthetic derivative of a vinca alkaloid used to treat neurological symptoms of cerebrovascular disease. Vinpocetine has been investigated for the treatment of Epilepsy.

Chemical structure of Vinpocetine
Mechanism
Curator reviewed
Formula / weight
C22H26N2O2 · 350.462 g/mol (avg)
Also known as
CERACTIN · ETHYL APOVINCAMIN-22-OATE
Code names
AY-27255

Resolves to

Compound
UNII543512OBTCCAS42971-09-5ChEMBLCHEMBL71752ChEBI32297PubChem443955
Clinical / RWD
RxNorm24506ATCN06BX18
Structure
InChIKeyDDNCQMVWWZOMLN-IRLDBZIGSA-NSMILES[H][C@]12N3CCC[C@@]1(CC)C=C(N1C4=CC=CC=C4C(CC3)=C21)C(=O)OCC
Targets
P30536TSPO

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,450Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
4Marketed productsAcross 2 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 28 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Vinpocetine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In